Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.

JAMA Netw Open · 2019 · PMC6902757 · PMID 31800067

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

There was a nonsignificant trend toward a lower incidence of HF hospitalizations among patients with an EF between 45% and 49% who were receiving β-blockers (hazard ratio, 0.68 [95% CI, 0.28-1.63]; P = .39).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.